4.3 Article

Urine cytology discrepancies - Frequency, causes, and outcomes

Journal

AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 127, Issue 6, Pages 946-953

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1309/XUVXFXMFPL7TELCE

Keywords

cytology; bladder cancer; patient safety; quality improvement; urine cytology

Categories

Funding

  1. AHRQ HHS [R01HS13321-01] Funding Source: Medline

Ask authors/readers for more resources

Although urine cytology is used for the earl); detection and surveillance of urothelial carcinoma, there has been little study of the frequency. causes, and outcomes of cytologic-histologic discrepancies. We obtained histologic follow-up in 361 (6.2%) of 5,785 voided, 124 (19.5%) of 636 lower tract instrumented, and 23 (33%) of 69 upper tract urinary cytologic specimens from 1 institution during a 2-year timeframe to determine diagnostic discrepancy frequency and outcomes. Cytologic-histologic discrepancies were observed in 208 (40.9%) cases with histologic followup, and the cause of discrepancy was interpretation and sampling in 35.1% and 63.0%, respectively. Of all discrepancies, 101 (48.6%) resulted in minimal or mild harm, consisting mainly of repeated testing and/or diagnostic delays. Severe harm never was observed. We conclude that current screening and surveillance methods that incorporate urine cytology are accurate in diagnosing urothelial cancer However, the current protocols result in potentially reducible errors that lead to unnecessary testing and diagnostic delays.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available